Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

Not specified

Primary Completion Date

July 31, 2016

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

KAD-1229

DRUG

Placebo

DRUG

Insulin

Trial Locations (1)

Unknown

Multiple Locations

All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT02154347 - Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter